3Ms Infection Prevention Division and Sage Products are working together to offer surgical staff and patients a new preoperative prepping kit to help address surgical site infection (SSI) risk within three main reservoirs of bacteria in the body: the nares, the oral cavity and the skin.
Each reservoir creates a need for a systematic intervention which may help reduce the incidence of surgical site infection (SSI). Patient flora is the leading cause of SSIs which result in as many as 3.7 million additional hospitalization days and an annual overall cost of 1.6 billion in the United States. (1,2) In an attempt to decrease infection trends and costs, Medicares reimbursement structure will be based on a pay-for-performance philosophy beginning in 2013. Facilities will be required to demonstrate a reduction in healthcare-acquired infections (HAI), under which SSIs are categorized, in order to receive full payment.
The Nose to Toes kit is a new system designed to reduce bacteria on the patients skin and in the oral cavity. This antiseptic solution does not impact a facilitys antibiotic stewardship program. The kit includes these three products:
-- 3M Skin and Nasal Antiseptic (Povidone-Iodine Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation-- reduces bacterial counts in the nares in one hour and maintains this reduction for at least 12 hours.(3)
-- 3M Peridex (Chlorhexidine Gluconate 0.12%) Oral Rinse and Sage® Ultra-soft Toothbrush --provides antimicrobial activity during oral rinsing.
-- Sage® 2% Chlorhexidine Gluconate Cloths -- Patient Preoperative Skin Preparation -- contains 500mg of rinse-free 2% CHG solution per cloth for rapid, broad spectrum skin antisepsis with persistent activity.
Packaged together, this comprehensive kit helps clinicians and staff control the process for preoperative prepping, eliminating patient non-compliance in these areas.
This simple intervention is easily and quickly applied in the preoperative environment. Reducing the patients skin flora before they enter the operating room promotes positive patient outcomes, says Scott Brown, president and COO of Sage Products.
Debra Rectenwald, president and general manager, 3M Infection Prevention Division, adds, By packaging our products together in a cost-effective, convenient kit, we are working together to achieve our mutual goals of reducing infections.
The Nose to Toes kit is exclusively available for sale from Sage Products. For Nose to Toes product information, contact your local Sage Products sales representative.
(1) CDC Guideline for Prevention of Surgical Site Infection, 1999. http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/SSI.pdf
(2) Martone WJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis. 33 Suppl 2 2001:S67-68.
(3) 3M, 12MS Study-05-011017, I2MS Study-05-011100.
Â
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.